Add to Favorites Newsroom RSS Share
fb-shareRoswell Park Comprehensive Cancer Center
Buffalo, NY USA

Our News on Newswise

Newswise: photo_from_moonshot_press_release_smaller_image.jpg

Roswell Park Secures More Than $15.4 Million in New Funding for Cancer Research

Roswell Park researchers have received recent grant awards totaling more than $15.4 million. These competitive awards include the first National Institutes of Health funding to study a new electronic tobacco device and a state grant supporting...
13-Aug-2019 4:55 PM EDT Add to Favorites

Newswise: thanavala_for_web.jpg

Roswell Park Researchers Identify Immune Biomarker of Response in Patients With Advanced Liver Cancer

Roswell Park researchers have uncovered a biomarker that may help explain why some patients respond better than others to sorafenib, a chemotherapy commonly prescribed for patients with advanced liver cancer.
13-Aug-2019 4:45 PM EDT Add to Favorites

Newswise: PressReleaseHeatMap.jpg

Roswell Park Team Develops New Method of Tracking Cellular Changes Associated with Cancer

Researchers from Roswell Park have developed a new bioinformatics-based approach for monitoring key changes in cancer cells — a data-driven method that might help to enhance and personalize cancer treatment.
1-Aug-2019 2:05 PM EDT Add to Favorites

Newswise: BenSeonLab.jpg

Immunotherapy-Chemo Combo Based on Work of Roswell Park’s Dr. Ben Seon Gets FDA Approval

A cancer therapy based on the work of Ben Seon, PhD, at Roswell Park Comprehensive Cancer Center has been approved by the U.S. Food and Drug Administration (FDA) for patients with an aggressive form of non-Hodgkin lymphoma.
19-Jun-2019 6:05 PM EDT Add to Favorites

Newswise: XRay-CT31.png

Roswell Park Physician Leads Development of New Multiple Myeloma Imaging Guidelines

Jens Hillengass, MD, Chief of Myeloma at Roswell Park Comprehensive Cancer Center, led an International Myeloma Working Group (IMWG) effort to compile new recommendations for imaging techniques that offer more sensitive and accurate diagnosis and...
13-Jun-2019 2:05 PM EDT Add to Favorites

Newswise: SurVaxM.jpg

ASCO 2019: Favorable Response for Brain Cancer Patients Receiving Combination Therapy With SurVaxM

With their phase II study in patients with aggressive brain cancer now completed, the developers of the cancer immunotherapy SurVaxM report that combination therapy with the vaccine was more effective than standard therapy for nearly all patients.
3-Jun-2019 4:50 AM EDT Add to Favorites

Newswise: NYSTEMMEdiaPackage.00_00_26_17.Still003.jpg

Patients’ Own Cells Do the Work in Roswell Park Immunotherapy Study Incorporating Adult Stem Cells

A clinical trial underway at Roswell Park Comprehensive Cancer Center will assess a brand-new immunotherapy approach — reprogramming a patient’s blood stem cells to generate a lasting supply of two types of immune cells — in patients with...
14-May-2019 10:05 AM EDT Add to Favorites

Newswise: GokulDasinLab2019_6.jpg

Researchers Uncover New Role for Tamoxifen in Triple-Negative Breast Cancers

In a new article in JNCI reporting the first known prognostic marker for triple-negative breast cancer, researchers provide evidence that a widely used breast cancer drug, tamoxifen, may be effective against this notoriously aggressive disease...
16-Apr-2019 11:05 AM EDT Add to Favorites

see all news

Our Experts on Newswise

Roswell Park: Racial Disparities From Cervical Cancer Are a Wake-Up Call

25-Jan-2017 10:05 AM EST

Dr. Igor Puzanov of @RoswellPark Cancer Institute Avail. To Comment on Chan/Zuckerberg $30b Pledge for #Medicalresearch

22-Sep-2016 3:05 PM EDT

Roswell Park's Dr. James Marshall Available to Interpret, Comment on Who Statement on Processed Meats and Cancer Risk

27-Oct-2015 5:05 PM EDT

Cancer-Specific Clinical Research Center: New Frontiers in Research at Roswell Park

Clinical trials are the frontier for targeted cancer drugs. Roswell Park Cancer Institute recently opened one of only a few clinical research centers in the U.S. focused exclusively on cancer. The Clinical Research Center, under the direction of...
4-Apr-2008 1:00 PM EDT

see all experts

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact to configure this module.


Roswell Park Comprehensive Cancer Center is a community united by the drive to eliminate cancer’s grip on humanity by unlocking its secrets through personalized approaches and unleashing the healing power of hope. Founded by Dr. Roswell Park in 1898, it is the only National Cancer Institute-designated comprehensive cancer center in Upstate New York. Learn more at, or contact us at 1-800-ROSWELL (1-800-767-9355) or


  • Christine Ambrosone

    Senior Vice President

    Cancer, Epidemology, Cancer Prevention, Breast Cancer, Health Disparities
  • Ermelinda Bonaccio

    Clinical Chief

    Cancer, Breast Cancer Screening, Radiology, Mammography, breast cancer early detection, Breast Cancer, Breast Imaging, breast biopsy
  • Stephen Edge

    Vice President for Healthcare Outcomes and Policy

    Breast Cancer, Breast Cancer Surgery, Surgery, cancer incidence, Health Care Delivery, Health Care Outcomes
  • Robert Fenstermaker

    Chair of Neurosurgery

    Neurosurgery, Glioblastoma, Brain Cancer, immunotheraphy, Cancer Vaccines
  • Andrei Gudkov

    Senior Vice President of Basic Science and the Gar

    Cancer Genetics, Cancer Therapies, Drug Discovery, Radiation effects
  • Khurshid Guru

    Chair, Department of Urology and Director of Robot

    Robotic Surgery, Bladder Cancer, Prostate Cancer, Cancer
  • Andrew Hyland

    Chair of Health Behavior

    Tobacco, Tobacco Control, tobacco policy, Epidemiologic, Public Health, e-cigarretes, vaping
  • Candace S. Johnson

    President & CEO

    Cancer, Cancer Research, Vitamin D, immunotheraphy, Cancer Vaccines, Genomics, Personalized Medicine, Cancer Therapies, Medical Research
  • Kara Kelly

    Waldemar J. Kaminski Endowed Chair of Pediatrics

    Pediatric Cancer, Hodgkin Lymphoma, pediatric leukemia, Cancer Therapies
  • Boris Kuvshinoff II

    Chief Medical Officer

    Liver Cancer, Pancreatic, Cancer, Pancreatic Cancer, abdominal cancer , Gastrointestinal Cancer, Stomach Cancer, Gallbladder Cancer
  • Kelvin Lee

    Jacobs Family Chair in Immunology

    Cancer, Cancer Immunology, immunotheraphy, Cancer Vaccines, Biotech, mutiple myeloma, Medical Oncology, Medical Research
  • Martin Mahoney

    Chair of the Department of Clinical Prevention

    Family Medicine, Primary Care, Preventive Medicine, Health Behavior, Lung Cancer, Smoking Cessation, HPV, Vaccination
  • Philip McCarthy

    Director of the Blood and Marrow Transplant Center

    Bone Marrow, Bone Marrow Transplant, Leukemia, Lymphoma, Multiple Myeloma, Cancer, Blood Cancer, hematologic oncology
  • Carl Morrison

    Executive Director of the Center for Personalized

    Genomics, Personalized Medicine, molecular pathology, Cancer, Cancer Genetics, Molecular Diagnostics, Medical Diagnostics
  • Kunle Odunsi

    Deputy Director, Chair of Gynecologic Oncology

    Cancer, Cancer Therapy, Immunotherapy, Cancer Vaccines, Vaginal Cancer, Cervical Cancer, Ovarian Cancer, Uterine Cancer
  • Igor Puzanov

    Director of Early Phase Clinical Trials Program an

    Novel Therapies, Melanoma, immunotheraphy, Cancer Vaccines, Personalized Medicine, Cancer
  • Mary Reid

    Director of Cancer Screening and Survivorship

    Cancer, Lung Cancer, Cancer Screening, Cancer Detection, Cancer Prevention, Epidemiology


Annie Deck-Miller
Sr. Media Relations Manager
Cancer research and treatment


Rebecca Vogt
Media Relations Specialist


Twitter twitter-icon

Chat now!